Magnetically Separable Macro Granules for Immunoassay Detection

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current immunoassay technologies face limitations in sensitivity and sample volume capacity due to the use of small beads that require long magnetic separation times and are prone to aggregation, and existing macro particle-based methods lack magnetic separation and automation capabilities.

Innovation Solution

The use of magnetically separable macroscopic granule particles (MGP) with sizes between 1 mm and 5 mm, coated with detection molecules, allows for rapid signal generation and high sensitivity in large sample volumes, enabling efficient magnetic separation and automation of ELISA processes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Area of stationary object

If small beads (micrometer and nanometer scale) are used for immunoassays, then the surface area to volume ratio is increased, but the magnetic separation time becomes very long and bead aggregation occurs

Engineering Contradiction:
Improvesurface areaVSAvoidmagnetic separation time
Core Design Contradiction:
Area of stationary objectVSLoss of time

Solution Approach 1:

The patent transitions from using small beads (0.1-10 μm) to large macroscopic granulate particles (1-5 mm), representing a dimensional change in particle size. This macroscopic scale provides sufficient surface area for immunoassay reactions while enabling rapid magnetic separation due to the larger mass and improved magnetic response, thereby resolving the contradiction between surface area requirements and separation time.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

Solution Approach 2:

The patent changes the physical parameter of particle size from micrometer/nanometer scale to millimeter scale. This parameter change fundamentally alters the magnetic separation characteristics, allowing large particles to be separated rapidly from sample matrices while maintaining adequate surface area for antibody-antigen binding through the macroscopic surface available on each particle.

Inventive Principle:
Principle #35Parameter changes

2Area of stationary object

If small beads are used for immunoassays, then the surface area is increased, but bead loss during magnetic separation increases

Engineering Contradiction:
Improvesurface areaVSAvoidbead loss
Core Design Contradiction:
Area of stationary objectVSLoss of substance

Solution Approach 1:

By transitioning to macroscopic granulate particles (1-5 mm), the patent reduces bead loss during magnetic separation. The larger size and mass of these particles prevent them from being lost in the sample matrix or during handling, while still providing sufficient surface area for effective immunoassay reactions.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

3Measurement precision

If larger sample volumes are used, then the sensitivity is improved, but the separation time and difficulty increase

Engineering Contradiction:
ImprovesensitivityVSAvoidseparation time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The use of macroscopic granulate particles (1-5 mm) enables the processing of large sample volumes (up to several milliliters) with rapid magnetic separation. The large particle size provides sufficient surface area for capturing analytes from extended sample volumes, while the magnetic properties ensure quick separation even from viscous or complex matrices, thereby improving sensitivity without proportionally increasing separation time.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

4Measurement precision

If conventional ELISA methods are used, then the sensitivity is achieved, but the device complexity and time consumption increase

Engineering Contradiction:
ImprovesensitivityVSAvoiddevice complexity
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent extracts the solid phase support from conventional ELISA plates and replaces it with magnetically separable macroscopic granulate particles. This extraction allows the immunoassay to be performed in a simplified format using standard laboratory equipment for magnetic separation, eliminating the need for specialized ELISA readers and complex plate-based protocols while maintaining sensitivity.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The macroscopic granulate particles self-organize and can be easily separated using simple magnetic fields without requiring complex automated ELISA systems. The large particles naturally settle and can be manipulated with basic magnetic separators, making the assay self-sufficient and reducing dependence on complex device infrastructure.

Inventive Principle:
Principle #25Self-service

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables sensitive detection of analytes in large sample volumes with reduced matrix effects and rapid separation, while allowing for automation and minimizing bead loss, surpassing the limitations of conventional bead-based and macro particle-based methods.

Implementation Method 1

The particles can be separated by means of a magnet

Methodology Applied
Scientific EffectMagnetic separation: Magnetism

Data Source

PatentUS20250012790A1Means and method for detecting analytes by means of macroscopic granulate particles
Publication Date: 2025.01.09 IST INNUSCREEN GMBH
  • US20250012790A1 patent drawing

AI summary

The invention relates to magnetically separable polymer-based macro granules for carrying out immunoassays for detecting highly diverse analytes for medical, biological and biotechnological sectors. The size of the macroscopic granulate particles is between 0.5 mm and 10 mm in cross-section, preferably between 1 mm and 5 mm. Preferably, the macro granules can be magnetically separated. According to a preferred embodiment, the polymer-based macro granules are located in a pipette tip.